Adequate 0 8 0 8 O
recovery 9 17 9 17 O
from 18 22 18 22 O
most 23 27 23 27 O
recent 28 34 28 34 O
systemic 35 43 35 43 O
or 44 46 44 46 O
local 47 52 47 52 O
treatment 53 62 53 62 B-treatment
for 63 66 63 66 O
cancer 67 73 67 73 B-cancer

Eastern 0 7 74 81 B-clinical_variable
Cooperative 8 19 82 93 I-clinical_variable
Oncology 20 28 94 102 I-clinical_variable
Group 29 34 103 108 I-clinical_variable
( 35 36 109 110 I-clinical_variable
ECOG 36 40 110 114 I-clinical_variable
) 40 41 114 115 I-clinical_variable
Performance 42 53 116 127 I-clinical_variable
Status 54 60 128 134 I-clinical_variable
0 61 62 135 136 B-lower_bound
- 62 63 136 137 O
2 63 64 137 138 B-upper_bound

For 0 3 139 142 O
female 4 10 143 149 B-gender
participants 11 23 150 162 I-gender
of 24 26 163 165 O
childbearing 27 39 166 178 O
potential 40 49 179 188 O
and 50 53 189 192 O
male 54 58 193 197 O
participants 59 71 198 210 O
, 71 72 210 211 O
willingness 73 84 212 223 B-contraception_consent
to 85 87 224 226 I-contraception_consent
use 88 91 227 230 I-contraception_consent
acceptable 92 102 231 241 I-contraception_consent
methods 103 110 242 249 I-contraception_consent
of 111 113 250 252 I-contraception_consent
contraception 114 127 253 266 I-contraception_consent

Histologically 0 14 267 281 O
or 15 17 282 284 O
cytologically 18 31 285 298 O
confirmed 32 41 299 308 O
diagnosis 42 51 309 318 O
of 52 54 319 321 O
unresectable 55 67 322 334 O
Stage 68 73 335 340 B-cancer
IIIb 74 78 341 345 I-cancer

History 0 7 346 353 O
of 8 10 354 356 O
malignancy 11 21 357 367 B-cancer
other 22 27 368 373 O
than 28 32 374 378 O
NSLCL 33 38 379 384 B-cancer
within 39 45 385 391 O
5 46 47 392 393 B-upper_bound
years 48 53 394 399 I-upper_bound
prior 54 59 400 405 I-upper_bound
to 60 62 406 408 O
screening 63 72 409 418 O

Known 0 5 419 424 O
human 6 11 425 430 B-chronic_disease
immunodeficiency 12 28 431 447 I-chronic_disease
virus 29 34 448 453 I-chronic_disease
( 35 36 454 455 I-chronic_disease
HIV 36 39 455 458 I-chronic_disease
) 39 40 458 459 I-chronic_disease
positivity 41 51 460 470 O

Significant 0 11 471 482 O
cardiovascular 12 26 483 497 B-chronic_disease
disease 27 34 498 505 I-chronic_disease
, 34 35 505 506 O
such 36 40 507 511 O
as 41 43 512 514 O
New 44 47 515 518 B-clinical_variable
York 48 52 519 523 I-clinical_variable
Heart 53 58 524 529 I-clinical_variable
Association 59 70 530 541 I-clinical_variable
cardiac 71 78 542 549 I-clinical_variable
disease 79 86 550 557 I-clinical_variable
( 87 88 558 559 O
Class 88 93 559 564 B-lower_bound
II 94 96 565 567 I-lower_bound
or 97 99 568 570 O
greater 100 107 571 578 O
) 107 108 578 579 O
, 108 109 579 580 O
myocardial 110 120 581 591 B-chronic_disease
infarction 121 131 592 602 I-chronic_disease
, 131 132 602 603 O
or 133 135 604 606 O
cerebrovascular 136 151 607 622 B-chronic_disease
accident 152 160 623 631 I-chronic_disease
within 161 167 632 638 O
3 168 169 639 640 B-upper_bound
months 170 176 641 647 I-upper_bound
prior 177 182 648 653 I-upper_bound
to 183 185 654 656 O
randomization 186 199 657 670 O
, 199 200 670 671 O
unstable 201 209 672 680 O
arrhythmias 210 221 681 692 B-chronic_disease
, 221 222 692 693 O
or 223 225 694 696 O
unstable 226 234 697 705 B-chronic_disease
angina 235 241 706 712 I-chronic_disease

Symptomatic 0 11 713 724 O
, 11 12 724 725 O
untreated 13 22 726 735 O
CNS 23 26 736 739 B-cancer
metastases 27 37 740 750 I-cancer

malignancies 0 12 751 763 B-cancer
with 13 17 764 768 O
negligible 18 28 769 779 O
risk 29 33 780 784 O
of 34 36 785 787 O
metastasis 37 47 788 798 B-cancer
or 48 50 799 801 O
death 51 56 802 807 O

